SCHEMBL158236

SCHEMBL158236

Nc1ccc(N2CCNCC2=O)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A3 Q01959 2/20 0.44
MAP4K1 Q92918 1/20 0.39
PIM1 P11309 3/20 0.39
PIM3 Q86V86 1/20 0.39
WEE1 P30291 1/20 0.38
CHRNB2 P17787 4/20 0.38
CHRNA4 P43681 4/20 0.38
MAPKAPK2 P49137 1/20 0.37
CDK4 P11802 1/20 0.36
CDK6 Q00534 1/20 0.36
HTR6 P50406 1/20 0.36
KDM4E B2RXH2 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
ROCK2 O75116 1/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
GCK P35557 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291536 0.91 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3MAP4K1PIM1
Tert-Butyl Formate SCHEMBL27844205 0.86 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3MAP4K1PIM1
SCHEMBL5158426 0.86 HTR6 (0.43) SLC6A2PIM1PIM3CHRNB2CHRNA4
SCHEMBL255543 0.83 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3MAP4K1PIM1
SCHEMBL255556 0.83 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3MAP4K1PIM1
SCHEMBL21414395 0.80 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3MAP4K1PIM1
SCHEMBL3594508 0.80 CHRNB2 (0.56) SLC6A2SLC6A4SLC6A3MAP4K1WEE1
SCHEMBL15341607 0.80 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3MAP4K1PIM1
SCHEMBL18291708 0.79 SMN1; SMN2 (0.42) PIM1PIM3CHRNB2CHRNA4CDK4
Hydrochloric Acid SCHEMBL1583990 0.79 CHRNB2 (0.54) SLC6A2SLC6A4SLC6A3MAP4K1WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016194831-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 帝人ファーマ株式会社 2016-12-08 WO disclosed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 WO disclosed
EP-2611790-A1 PYRIDINONES/PYRAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF Gilead Connecticut, Inc. (US) 2013-07-10 EP disclosed
WO-2012031004-A1 PYRIDINONES/PYRAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF GILEAD CONNECTICUT, INC. (US) 2012-03-08 WO disclosed
EP-1742634-A1 POLYCYCLIC PYRIMIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAgen, Incorporated (US) 2007-01-17 EP disclosed
WO-2005099711-A1 POLYCYCLIC PYRIMIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed